
|Articles|September 1, 2004
Product preferencing tied to benefit design options
While plan managers have been doing it for nearly two decades with oral medications that are paid on the pharmacy benefit, the product-preferencing process is relatively novel for injectable medications. The next natural discussion is the role of benefit designs in the management of the cost of injectable products, since this is closely tied to product preferencing.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Cobenfy in Practice: Hope, Hurdles, and the Next Chapter in Schizophrenia Care
2
FDA Approves Gazyva for Lupus Nephritis in Adults
3
AI in Ophthalmology: The Key to the Present Success Includes a CPT Code. The Future? Agentic AI That Doesn’t Wait To Be Told What To Do | AAO 2025
4
Making Sense of the Eye Pain-Headache Connection | AAO 2025
5






















































